The active ingredient is identical, so the transition is straightforward
Many people with B12 deficiency or pernicious anemia naturally lack sufficient detoxifying methyl donors, and have trouble clearing out the cyanide
Neelakantan H, Vance V, Wetzel MD, Wang HY, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jul;154:161-171. doi: 10.1016/j.bcp.2018.05.003. Epub 2018 May 5. PMID: 29738706; PMCID: PMC6015571
Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy
Typical protocol: AOD-9604 300 mcg in the morning (fasted) + ipamorelin 200-300 mcg before bed